Blog

by Vineti | May 30, 2019
In personalized therapies -- cell therapies, gene therapies, and neoantigen therapies -- a patient is not just the recipient of a drug product. The patient is the product.

by Marc Puich | May 15, 2019
Standing up the ecosystem your therapy will rely on requires a solid operational plan for how will your therapy move between your key stakeholders.

by Heidi Hagen | May 2, 2019
When it comes to cell and gene therapy, the four walls of your lab fall away fast.

by Marc Puich | April 24, 2019
There are many critical decisions to be made when moving a large-molecule biologic out of the lab into human trials.

by Heidi Hagen | April 23, 2019
In cell therapy, smarter labeling means greater safety and speed.

  • 1
  • 2
  • 3 (current)
Subscribe to our blog
Required
Required
Required
Required
Required
Required
Required
Required